NASDAQ:AGRX
Agile Therapeutics Stock News
$0.340
-0.0300 (-8.11%)
At Close: Mar 28, 2024
PRINCETON, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023 financial r
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
08:15am, Wednesday, 20'th Mar 2024
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2023 financial r
Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023
08:05am, Thursday, 26'th Oct 2023
Live Conference Call and Webcast at 8:30 a.m. ET PRINCETON, N.J.
Why Shares of Agile Therapeutics Jumped This Week
04:19pm, Thursday, 28'th Sep 2023
Agile is seeing strong revenue growth. The company only has one marketed product, a birth control patch.
Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08:05am, Tuesday, 05'th Sep 2023
PRINCETON, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairperson and Chief Executive Officer Al Altomari and
Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023
08:30am, Wednesday, 26'th Jul 2023
PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2023 financial results before t
Agile Therapeutics, Inc. (AGRX) Q1 2023 Earnings Call Transcript
07:09pm, Friday, 12'th May 2023
Agile Therapeutics, Inc. (NASDAQ:AGRX ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Matt Riley - Head, Investor Relations Al Altomari - Chairman & Chief Executive Off
Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023
08:00am, Monday, 08'th May 2023
PRINCETON, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report first quarter 2023 financial results after the
Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET
TEVA Beats Q4 Earnings Estimates, Sales Miss & Stock Down
09:48am, Thursday, 09'th Feb 2023
TEVA reports mixed Q4 results, beating earnings estimates, while sales slightly miss estimates. Stock down post earnings release.
Agile Therapeutics To Present At The Upcoming RHK Capital Disruptive Growth Conference
08:30am, Thursday, 01'st Dec 2022
PRINCETON, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it will participate in the RHK Capital Disruptive Growth
Agile Therapeutics, Inc. (AGRX) Q3 2022 Earnings Call Transcript
06:59pm, Monday, 07'th Nov 2022
Agile Therapeutics, Inc. (NASDAQ:AGRX ) Q3 2022 Results Conference Call November 7, 2022 4:30 PM ET Company Participants Matthew Riley - Head of Investor Relations Alfred Altomari - Chairman and Chief
Agile Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on Monday, November 7, 2022
08:30am, Wednesday, 26'th Oct 2022
Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET
Agile Therapeutics Announces Reorganization of Leadership Team
08:25pm, Friday, 07'th Oct 2022 GlobeNewswire Inc.
Appointment of Amy Welsh to Chief Commercial Officer Prioritizes Commercial Growth
Agile Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
12:30pm, Tuesday, 06'th Sep 2022 GlobeNewswire Inc.
PRINCETON, N.J., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that Chairman and Chief Executive Officer Al Altomari and Vice P